Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suoyang Gujing Pills for male premature ejaculation (kidney deficiency syndrome)
ChiCTR2300071963Phase 4Not yet recruiting
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- Feb 2023
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of suoyang gujing wan in premature ejaculation (PE) and kidney deficiency syndromes, sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Primary endpoint: Intravaginal ejaculatory latency time. Planned start Feb 2023; status: not yet recruiting.
02
Drugs
suoyang gujing wan
03
Conditions
premature ejaculation (PE)kidney deficiency syndromes
Beyond the preview
Go deeper on ChiCTR2300071963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300071963.